跳至主要内容
临床试验/NCT07749469
NCT07749469招募中不适用

Safety and Efficacy of Skincare Products for Managing Mild to Moderate Acne in Individuals With Sensitive Skin

USMARI Research & Innovation Centre1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2026年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
34
试验地点
1
主要终点
Comprehensive Acne Severity Scale Classification (CASS)

研究概览

简要总结

To investigate the safety and efficacy of a skincare regimen in individuals with mild to moderate acne and sensitive skin. The study duration is 4 weeks and the skin assessment will be carried out at baseline and week 4.

The main questions this study aims to answer are:

  1. To investigate the safety of the skincare regimen products in managing mild to moderate acne in individuals with sensitive skin.
  2. To determine the efficacy of the skincare regimen products in managing mild to moderate acne in individuals with sensitive skin.
  3. To assess the participants' satisfaction with the skincare regimen products in managing mild to moderate acne in individuals with sensitive skin.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy Malaysian women and men
  • Fitzpatrick skin type II-V
  • Age above 18 years old
  • Individuals with sensitive skin identify through sensitive skin survey (Corazza et al., 2022) and lactic acid sting test (LAST).
  • Individuals with mild to moderate acne, based on Comprehensive Acne Severity Scale (CASS)

排除标准

  • Pregnant or breastfeeding women, or those planning pregnancy during the study period.
  • Individuals with documented autoimmune diseases or other conditions that may affect immune response or skin barrier function.
  • Individuals with a history of severe skin sensitivity reactions, including frequent intense erythema, swelling, or intolerable burning in response to topical products.
  • Individuals with severe acne requiring medical treatment or systemic treatment such as nodulocystic acne.
  • Individuals with active inflammatory or allergic dermatological conditions affecting the face, such as atopic dermatitis, eczema, or psoriasis, which may compromise skin barrier function or interfere with study assessments.
  • Individuals who have undergone cosmetic or dermatological procedures such as -chemical peel, microneedling, or any procedures aimed at improving acne, within 3 months prior to the study.
  • Individuals currently taking medical or hormonal treatments that may interfere with study outcomes, including anti-inflammatory agents, corticosteroids, or other medication interfering with study objectives.
  • Individuals with known allergy or hypersensitivity to any ingredients found in the product.

研究组 & 干预措施

Skincare regimen

Other

The skincare regimen consist of cleanser, toner, serum, day cream and night cream

干预措施: Cleanser (Other)

Skincare regimen

Other

The skincare regimen consist of cleanser, toner, serum, day cream and night cream

干预措施: Toner (Other)

Skincare regimen

Other

The skincare regimen consist of cleanser, toner, serum, day cream and night cream

干预措施: Serum (Other)

Skincare regimen

Other

The skincare regimen consist of cleanser, toner, serum, day cream and night cream

干预措施: Day cream (Other)

Skincare regimen

Other

The skincare regimen consist of cleanser, toner, serum, day cream and night cream

干预措施: Night cream (Other)

结局指标

主要结局

Comprehensive Acne Severity Scale Classification (CASS)

时间窗: baseline, week 4

Improvement of acne lesions will be assessed by blinded clinician at W0 and W4 of the study, using CASS. Acne severity was graded using a 6-point scale ranging from Grade 0 (clear) to Grade 5 (very severe). Grade 0 (clear)= No lesions to barely noticeable ones. Very few scattered comedones and papules; Grade 1 (almost clear) = Hardly visible from 2.5 metres away. A few scattered comedones, few small papules, and very few pustules; Grade 2 (mild)= Easily recognisable; less than half of the affected area is involved. Many comedones, papules, and pustules; Grade 3 (moderate)= More than half of the affected area is involved. Numerous comedones, papules, and pustules; Grade 4 (severe)= Entire area is involved. Covered with comedones, numerous pustules and papules, a few nodules and cyst; Grade 5 (very severe)= Highly inflammatory acne covering the affected area, with nodules, and cyst present.

Acne lesion counts

时间窗: baseline, week 4

Acne lesion counts will be performed by a blinded clinician. It will involve quantifying the open comedones, closed comedones, papules, pustules, nodules, and cysts. Lesions will be assessed across 5 facial regions: right forehead, left forehead, right cheek, left cheek, and chin. The nose and perinasal area will be excluded from analysis.

次要结局

  • Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability](4 weeks)
  • Participant satisfaction(week 4)

研究者

发起方
USMARI Research & Innovation Centre
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验